2018-11-23| PartnerAsia-Pacific

Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 2 Program

by Rajaneesh K. Gopinath
Share To
Med X Tech Summit Asia

By Rajaneesh K. Gopinath, Ph.D.

Proudly co-organized by GeneOnline, the global biotech conference brings key opinion leaders comprising healthcare professionals and technology giants under one roof promoting scientific exchange and business partnerships. The event is to be held from Nov 29 – 30, 2018 at the Grande Luxe Banquet, Taipei, Taiwan.

The second day of MEDTEX 2018 boasts of two sessions, a morning session that covers expert panel discussions on state-of-the-art technologies in health security systems followed by lunch and a post lunch session on Global healthcare innovation strategy.

The following are some of the major highlights on the second day of the conference.

1) The inaugural panel discussion would focus on the rapidly growing technology of Blockchain and Electronic Health Security in Healthcare. Moderated by Yuan Yao, Chief Data Scientist at PwC, the discussion includes Mohammed Tayeb (Medicalchain), Alexandra Tinsman (NEM Foundation) and Emma Hossack (Extensia) as speakers.

The second panel discussion is on the topic of “Designing an Intelligent Healthcare Ecosystem. It is moderated by Ted Chang, CTO of Quanta Computer. Panel speakers Keren Priyadarshini (Microsoft), David Hansen (CSIRO), Vitaly Herasevich (Mayo Clinic) and Daniel Tse (Google AI) will grace us with their insights.

2) The Luncheon will witness the Highlights on Singapore Biotechnology Ecosystem and Innovation. Yan-Lin Lye of Cambridge consultants will participate and moderate the discussion that also includes Whye-Kei Lye (Nanyang Technological University), Johnson Chen (CapBridge/ClearBridge) and Hsien-Hui Tong (SGInnovate).

3) Dr. Pan-Chyr Yang, VP of IBMI will deliver the opening remarks of the third and final session of Med x Tech Summit Asia 2018. This session is one of the key features of the event where panel discussions will be held on the topic of Global Healthcare Innovation Strategy. Major highlights of the Bioinnovation stadium include discussions from Markus Kalousek from Novartis and Yong-Hui Shi from Medtronic China Venture Fund. Their discussions are expected to provide valuable inputs on how to build healthcare innovation cluster and startup strategy and how potential candidates are evaluated. Another main attraction is the talk by Karin Mayer Rubinstein who will share with us, their latest technology from Israel Advanced Technology Industries (IATI). Besides, countries like Australia, USA, and UK will address their own unique biotechnology ecosystems. The event will be concluded with the awarding ceremony of National Innovation Award 2018.

MEDTEX and Taiwan Healthcare+ Expo strategically connects IT, biotech, pharmaceuticals, precision medicine and health management industries with global biomedical innovators. GeneOnline and co-organizers have carefully handpicked the key opinion leaders from diverse industry backgrounds to provide a wholesome learning experience for attendees about the latest technology and market trends in addition to fostering industry partnerships. Healthcare and business professionals must take advantage of this opportunity.

To register for the event, please visit


© All rights reserved. Collaborate with us:
Related Post
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
CVS Adds Oak Street Health In $10.6 Billion Buy To Boost Primary Care Offerings
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
Comparing ESG Regulations in the U.S., the U.K., and the EU
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
Scroll to Top